CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 28 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,510 | -10.9% | 5,032 | -30.7% | 0.00% | – |
| Q2 2023 | $10,677 | +96963.6% | 7,263 | +22.5% | 0.00% | – |
| Q1 2023 | $11 | +37.5% | 5,930 | +71.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 3,467 | -1.8% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 3,531 | -27.9% | 0.00% | – |
| Q2 2022 | $10,000 | +25.0% | 4,898 | +69.8% | 0.00% | – |
| Q1 2022 | $8,000 | -72.4% | 2,885 | -53.3% | 0.00% | -100.0% |
| Q4 2021 | $29,000 | +123.1% | 6,179 | +33.9% | 0.00% | – |
| Q3 2021 | $13,000 | +550.0% | 4,614 | +491.5% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 780 | -4.8% | 0.00% | – |
| Q1 2021 | $2,000 | -84.6% | 819 | -82.4% | 0.00% | – |
| Q4 2020 | $13,000 | +30.0% | 4,661 | +43.3% | 0.00% | – |
| Q3 2020 | $10,000 | +66.7% | 3,253 | +94.2% | 0.00% | – |
| Q2 2020 | $6,000 | +500.0% | 1,675 | +805.4% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 185 | +71.3% | 0.00% | – |
| Q4 2019 | $1,000 | -94.1% | 108 | -95.8% | 0.00% | -100.0% |
| Q2 2019 | $17,000 | +750.0% | 2,596 | +670.3% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 337 | +25.3% | 0.00% | – |
| Q4 2018 | $2,000 | -91.7% | 269 | -93.6% | 0.00% | -100.0% |
| Q3 2018 | $24,000 | +50.0% | 4,191 | +57.0% | 0.00% | +100.0% |
| Q2 2018 | $16,000 | +433.3% | 2,669 | +519.3% | 0.00% | – |
| Q1 2018 | $3,000 | -40.0% | 431 | -40.2% | 0.00% | -100.0% |
| Q4 2017 | $5,000 | +66.7% | 721 | +66.1% | 0.00% | – |
| Q3 2017 | $3,000 | -57.1% | 434 | -57.5% | 0.00% | -100.0% |
| Q2 2017 | $7,000 | – | 1,022 | +2589.5% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 38 | -97.1% | 0.00% | -100.0% |
| Q3 2016 | $7,000 | – | 1,314 | +1214.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 100 | -94.3% | 0.00% | -100.0% |
| Q1 2016 | $8,000 | +100.0% | 1,749 | +137.0% | 0.00% | 0.0% |
| Q4 2015 | $4,000 | – | 738 | +4820.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 15 | -96.8% | 0.00% | – |
| Q2 2015 | $3,000 | +200.0% | 472 | +99.2% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 237 | +61.2% | 0.00% | – |
| Q4 2014 | $1,000 | -87.5% | 147 | -91.7% | 0.00% | -100.0% |
| Q1 2014 | $8,000 | 0.0% | 1,781 | +5.5% | 0.00% | 0.0% |
| Q3 2013 | $8,000 | +166.7% | 1,688 | +173.6% | 0.00% | – |
| Q2 2013 | $3,000 | – | 617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Financial Planning, Inc. | 22,031 | $46,000 | 0.03% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 189,048 | $392,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $595,000 | 0.01% |
| Renaissance Technologies | 622,228 | $1,291,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $390,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $6,000 | 0.00% |
| BlackRock Inc. | 140,248 | $292,000 | 0.00% |
| Citadel Advisors | 32,300 | $67,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28,900 | $60,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 34,592 | $72,000 | 0.00% |